The U.S. surgeon general called for warning labels on alcoholic beverages last week, citing the link between alcohol and ...

The Head and Neck Radiation Oncology Group (GORTEC) announced significant improvement in disease-free survival for locally ...

Post-operative nivolumab significantly improved disease-free survival in resected locally advanced head and neck cancer, ...

Multiple TIGIT clinical data readouts anticipated throughout 2025, including >400 patients from two Phase 2 trials and one Phase 1/2 assessing belrestotug + dostarlimab in 1L NSCLC and 1L HNSCC - ...

Indore (Madhya Pradesh): The Department of Atomic Energy (DAE), Government of India, has sanctioned a grant of nearly Rs 1 ...

A new artificial intelligence tool combines data from medical images with text to predict cancer prognoses and treatment responses.

Developed at the University of Michigan, MyHPVscore is a highly accurate blood test that can detect human papilloma virus-related head and neck cancer by measuring fragments of tumor DNA in a ...

Researchers observed a dose-response relationship between daily tea consumption and the risk of head and neck cancer, hypopharyngeal cancer, and laryngeal cancer.

People who drank more than 4 cups a day “had 17% lower odds of having head and neck cancer overall, and 30% lower odds of ...

To start the year right, Fred Hutch scientists, providers and a patient advocate share tips to help readers keep up with the ...

A meta-analysis found that peer reviews in radiation oncology led to recommendations to change treatment plans in more than ...

GORTEC, known as Head and Neck Radiation Oncology Group, today announced that the randomized Phase 3 NIVOPOSTOP GORTEC 2018-01 trial evaluating nivolumab, Bristol Myers Squibb's anti-PD-1 therapy, as ...